Management of Low Free Testosterone with Normal SHBG and Total Testosterone

Diagnostic Assessment

The patient's laboratory values show a classic pattern of isolated low free testosterone with normal total testosterone and normal SHBG, requiring treatment if accompanied by clinical symptoms of hypogonadism, as recommended by the Endocrine Society 1, 2
Free testosterone measurement is essential in cases where total testosterone and SHBG levels may not reflect true testosterone status, according to the American Urological Association 1, 3

Before initiating treatment, confirm the presence of symptoms associated with testosterone deficiency, such as decreased energy, fatigue, depression, reduced motivation, poor concentration, reduced sex drive, or erectile dysfunction, as suggested by the American College of Physicians 3, 1
Physical examination should evaluate body habitus, virilization status, body mass index, waist circumference, presence of gynecomastia, and testicular size and consistency, as recommended by the American Academy of Family Physicians 3, 1

Measure morning luteinizing hormone (LH) levels to determine if hypogonadism is primary or secondary, and measure serum prolactin to rule out hyperprolactinemia, as suggested by the Endocrine Society 3, 1
Consider measuring estradiol if the patient presents with breast symptoms or gynecomastia, as recommended by the American College of Obstetricians and Gynecologists 3

For patients with confirmed low free testosterone, testosterone replacement therapy is indicated, with transdermal testosterone preparations generally preferred as first-line options, as recommended by the American Urological Association 2, 1
Alternative options include testosterone injections and implantable testosterone pellets, with the method of testosterone replacement individualized based on patient preference and specific patient factors, as suggested by the European Association of Urology 2

After initiating treatment, monitor testosterone levels at 2-3 months and after any dose change, targeting normal free testosterone levels rather than just total testosterone, as recommended by the Endocrine Society 2, 1
Once stable levels are confirmed, monitoring every 6-12 months is typically sufficient, with levels measured midway between injections for patients receiving testosterone injections, as suggested by the American College of Physicians 2